CELMUNO mycophenolate mofetil 500 mg tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

mycophenolate mofetil, Quantity: 500 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Mycophenolate mofetil

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; macrogol 4000; polyvinyl alcohol; iron oxide black; lecithin

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

50 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. ,Prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.

Sommarju tal-prodott:

Visual Identification: Lavender, convex, capsule-shaped tablet with "MO 500" on one side and Arrow logo on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-01-18